Published on Friday, 12 February 2016 15:36
Oricula Therapeutics LLC., a biotech company based in Seattle, Washington State is working to develop the first medication approved to prevent hearing loss related to aminoglycoside antibiotics.
PR Newswire reports that the grant of USD 2 million was...